Psychoactive Drugs Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Psychoactive Drugs stocks.

Psychoactive Drugs Stocks Recent News

Date Stock Title
Jul 1 AZN AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
Jul 1 AZN AstraZeneca COVID prevention antibody gets EU fast-track review
Jul 1 SNDL Is SNDL Inc. (SNDL) a Good Pot Stock to Buy Now?
Jul 1 AZN Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 28 AZN Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Jun 28 MNMD Mind Medicine to join Russell 2000 index
Jun 28 MNMD MindMed to be Included in Russell 2000® and Russell 3000® Indexes
Jun 26 MAPS Insider Sale: Director Scott Gordon Sells Shares of WM Technology Inc (MAPS)
Jun 26 MAPS Insider Sale at WM Technology Inc (MAPS): Director Fiona Tan Sells 113,672 Shares
Jun 26 MNMD Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
Jun 26 AZN AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Jun 26 AZN Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
Jun 26 AZN China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients
Jun 26 AZN AstraZeneca’s Tagrisso with chemo approved in China for lung cancer
Jun 26 AZN AstraZeneca’s Tagrisso receives approval in Japan for lung cancer
Jun 25 AZN AstraZeneca's Oncology Success: Fueling Future Growth
Jun 25 AZN AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio
Jun 25 AZN AstraZeneca lung cancer therapy Imfinzi fails in late-stage trial
Jun 25 AZN AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung Cancer, But Hits Primary Goal In Phase 3 Bladder Cancer Study
Jun 25 MAPS Weedmaps and BLAZE® Solutions Partner to Launch Comprehensive Global Cannabis Product Catalog
Psychoactive Drugs

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens; for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.
Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g., euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing. Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences. In addition, sustained use of some substances may produce physical or psychological dependence or both, associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation attempts to reduce addiction, through a combination of psychotherapy, support groups, and other psychoactive substances. Conversely, certain psychoactive drugs may be so unpleasant that the person will never use the substance again. This is especially true of certain deliriants (e.g. Jimson weed), powerful dissociatives (e.g. Salvia divinorum), and classic psychedelics (e.g. LSD, psilocybin), in the form of a "bad trip".
Psychoactive drug misuse, dependence and addiction have resulted in legal measures and moral debate. Governmental controls on manufacture, supply and prescription attempt to reduce problematic medical drug use. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers. Popular campaigns to allow certain recreational drug use (e.g. cannabis) are also ongoing.

Browse All Tags